Saturday 17 October 2026
Export MCK’s income statement to Excel — free account
McKesson Corporation
MCK Healthcare Medical Distribution
McKesson Corporation’s revenue for fiscal 2026 (year ended March 2026) was $403.4 billion, up 12.4% from fiscal 2025. In the quarter to June 2026, revenue grew 7.72%, EPS fell 17.7%, free cash flow grew 66.4% and total debt rose 10.5%, each against the same quarter a year earlier. Member of the S&P 500; dividend growth for twenty-five consecutive years, revenue growth for ten.
1,006.92
8.28
+0.83%
Follow MCK
| Jun '26 | Mar '26 | Dec '25 | Sep '25 | Older periods | |
|---|---|---|---|---|---|
| (168.45%) | (274.39%) | (240.78%) | (201.80%) |
+8 more TTM periods Free account |
|
Piotroski F-Score |
7 | 7 | 7 | 7 | |
| 5.41% | 6.05% | 5.59% | 5.15% | ||
ROIC |
70.49% | 66.20% | 45.30% | 43.80% | |
Return on Tangible Assets |
(94.97%) | (66.70%) | (74.83%) | (73.10%) | |
Average Days of Receivables |
26.92 | 25.32 | 25.88 | 26.67 | |
Free Cash Flow per Share |
51.77 | 43.77 | 78.28 | 48.45 | |
Free Cash Flow |
6,145.00 | 5,410.00 | 9,644.00 | 6,008.00 | |
Capital Expenditures |
(708.00) | (745.00) | (838.00) | (859.00) | |
| Other line items | |||||
Cash ROIC |
38.20% | 39.16% | 70.30% | 38.74% | |
Accounts Receivable Turnover |
14.06 | 15.05 | 14.73 | 14.46 | |
Accounts Payable Turnover |
6.51 | 6.75 | 6.95 | 6.54 | |
Inventory Turnover |
15.43 | 16.48 | 15.08 | 14.84 | |
Average Days of Payables |
58.74 | 56.29 | 57.71 | 59.58 | |
Days of Inventory on Hand |
24.20 | 22.72 | 25.74 | 25.55 | |
Tax Rate |
(0.18) | (0.18) | (0.19) | (0.18) | |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Selling, General and Administrative Expense of Revenue |
1.99% | 2.01% | 2.08% | 2.14% | |
Share Based Compensation of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Interest Coverage |
23.62 | 25.15 | 24.47 | 22.37 | |
Operating CF/Net income |
1.49 | 1.29 | 2.42 | 1.70 | |
Depreciation/Fixed assets |
0.29 | 0.27 | 0.26 | 0.25 | |
Capex/Depreciation |
(0.92) | (1.02) | (1.23) | (1.32) | |
Revenue per Share |
3,462.37 | 3,264.00 | 3,230.18 | 3,121.73 | |
Operating CF per Share |
57.73 | 49.80 | 85.08 | 55.38 | |
Capex per Share |
(5.96) | (6.03) | (6.80) | (6.93) | |
Capex to Sales |
0.00 | 0.00 | 0.00 | 0.00 |
Columns are period end dates